Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Better nutrition may reduce fecal incontinence in stroke patients by lowering inflammation and improving antioxidant levels.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

Regulatory T cells play a key role in different types of hair loss.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

IVIG therapy was linked to hair regrowth in two patients with hair loss, but it's not recommended due to its risks and costs.

COVID-19 can trigger a relapsing form of hair loss, requiring long-term treatment strategies.

IL-17 is a key target for treating inflammatory skin diseases, especially psoriasis.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Vitiligo and alopecia areata may have similar causes despite their differences.

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Cicatricial alopecia may be caused by immune attacks on hair follicles, gland issues, or stem cell damage.

Alopecia areata helps study T cell-driven autoimmune diseases.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Dystonia may be part of PAS-4 and linked to immune issues.

Prolactin affects skin health and may lead to new treatments for skin and hair issues.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Childhood and adult height, and early immune-related hospitalizations increase testicular cancer risk, while baldness, larger families, and sports reduce it.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

JAK inhibitors show promise for treating alopecia areata but their effectiveness and safety are still debated.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Minoxidil helps hair regrowth by stimulating hair follicles and reducing immune responses.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Fat-derived stem cells show promise for treating skin issues and improving wound healing, but more research is needed to confirm the best way to use them.

HuR is essential for Treg function and preventing autoimmunity.

Alopecia areata is influenced by genetics and immune system factors, and better understanding could improve treatments.